Viewing entries tagged
access to medicines


Given that no official entity is entrusted with making essential medicines on the WHO Essential Medicines List affordable, we suggest that the WHO take a leadership role in addressing this policy gap. Here, we propose a mechanism that could help.

Sandeep Kishore, Rachel Kiddell-Monroe, and Ruth Lopert
- United Nations Secretary-General’s High-Level Panel on Access to Medicines
February 16, 2016

WHO Takes a Big Step to Promote Cancer Treatment Worldwide

Even in countries like the USA, where the most current cancer treatments are readily available, cost is a serious barrier. In lower-income settings, pricey cancer medications can be impossible to obtain. We discuss the expansion of WHO’s “essential medicines” list to include some high-priced cancer medications and the potential impact it may have on accessibility.

Jordan Jarvis and Sandeep Kishore
-  The Lancet United States of Health Blog
May 18, 2015

Unlikely Allies

The recent Executive Board proceedings of the World Health Organization provided new ground for unlikely allies South Africa and Australia, as both struggle to temper intellectual property laws in the interest of public health. We observed the proceedings as non-governmental organization representatives.

Sandeep Kishore and Kavitha Kolappa
- The Huffington Post
February 14, 2014